Company
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| MT-401-OTS | Phase 1 | Acute Myeloid Leukemia, in Relapse |
Latest
No recent events.
Follow Marker Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.